Considering all of the controversies that have erupted over the years regarding this product, it would not be surprising to see a large number of Medtronic Infuse lawsuit filings.
New York, New York (PRWEB) April 06, 2013
The Medtronic Infuse lawyers at Bernstein Liebhard LLP note that a new report published by MassDevice.com predicts that hundreds of Medtronic Infuse Bone Graft lawsuits could ultimately be filed by individuals who allegedly suffered serious complications due to the controversial bone growth protein. According to the report, a Medtronic Infuse lawsuit was recently filed in U.S. District Court, Southern District of Ohio, involving 88 patients who allegedly received the bone protein in experimental spine surgeries without their consent. In addition to Medtronic Inc., the lawsuit names the Ohio surgeon who performed the surgeries and was a paid consultant to Medtronic. According to court documents, all of the plaintiffs allege the doctor “performed medically unnecessary, experimental spines surgeries on plaintiffs using falsely and improperly marketed Medtronic medical devices and drugs." (Case No. 1:13-cv-00202-SSB). *
“Considering all of the controversies that have erupted over the years regarding this product, it would not be surprising to see a large number of Medtronic Infuse lawsuit filings,” says Bernstein Liebhard LLP, a nationwide law firm currently evaluating Medtronic Infuse Bone Graft lawsuits on behalf of individuals who may have suffered respiratory problems, nerve damage, and wrongful death, allegedly associated with use of Infuse.
Medtronic Infuse Complications
Medtronic Infuse Bone Graft was approved by the U.S. Food & Drug Administration (FDA) in 2002 for stimulating spinal bone growth in patients with a degenerative disease affecting the lower spine. In 2008, the FDA warned that Infuse Bone Graft had been associated with serious complications when used off-label in cervical spine fusions, including excessive swelling in the neck, compressed airways, difficulty breathing, problems swallowing and nerve damage.**
Since the FDA warning, Medtronic Infuse has been the subject of growing controversy, some of which have raised questions about Medtronic's financial relationships with doctors, according to Bernstein Liebhard. This past October, a U.S. Senate Finance Committee report raised disturbing questions about the research used to back Infuse. The report found that Medtronic paid out $210 million in royalties, consulting fees, and other payments to the doctors who co-authored the Medtronic-sponsored Infuse studies. Among other things, Senate investigators charged that Medtronic deliberately manipulated the studies to downplay Infuse side effects and promote off-label use of the product.***
In 2011, The Spine Journal raised similar questions when it dedicated an entire issue to studying the risks of the recombinant bone morphogenetic protein-2, or BMP-2, used in Medtronic Infuse Bone Graft. The journal’s investigation found that more than a dozen Medtronic-funded studies downplayed or entirely omitted evidence of safety issues associated with Infuse.****
The Medtronic Infuse lawyers at Bernstein Liebhard LLP are offering free lawsuit consultations to anyone allegedly injured by Medtronic Infuse Bone Graft. Victims of serious Infuse complications may be entitled to compensation for their medical care, pain and suffering, and other damages. A wealth of information regarding Medtronic Infuse Bone Graft lawsuits is available on the Firm’s website. For more information about Medtronic Infuse lawsuits, please contact one of our attorneys by calling 877-779-1414.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP